BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8691463)

  • 1. Active site directed inhibition of estrone sulfatase by nonsteroidal coumarin sulfamates.
    Woo LW; Purohit A; Reed MJ; Potter BV
    J Med Chem; 1996 Mar; 39(7):1349-51. PubMed ID: 8691463
    [No Abstract]   [Full Text] [Related]  

  • 2. Steroidal and nonsteroidal sulfamates as potent inhibitors of steroid sulfatase.
    Woo LW; Howarth NM; Purohit A; Hejaz HA; Reed MJ; Potter BV
    J Med Chem; 1998 Mar; 41(7):1068-83. PubMed ID: 9544207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent active site-directed inhibition of steroid sulphatase by tricyclic coumarin-based sulphamates.
    Woo LL; Purohit A; Malini B; Reed MJ; Potter BV
    Chem Biol; 2000 Oct; 7(10):773-91. PubMed ID: 11033081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The design, synthesis, and biochemical evaluation of derivatives of biphenyl sulfamate-based compounds as novel inhibitors of estrone sulfatase.
    Ahmed S; James K; Owen CP
    Biochem Biophys Res Commun; 2002 May; 294(1):180-3. PubMed ID: 12054760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biochemical evaluation of AC ring mimics as novel inhibitors of the enzyme estrone sulfatase (ES).
    Ahmed S; James K; Owen CP; Patel CK
    Bioorg Med Chem Lett; 2002 May; 12(10):1343-6. PubMed ID: 11992773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stilbene-based inhibitors of estrone sulfatase with a dual mode of action in human breast cancer cells.
    Walter G; Liebl R; von Angerer E
    Arch Pharm (Weinheim); 2004 Dec; 337(12):634-44. PubMed ID: 15597397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of (p-O-sulfamoyl)-N-alkanoyl-phenylalkyl amines as non-steroidal estrone sulfatase inhibitors.
    Kolli A; Chu GH; Rhodes ME; Inoue K; Selcer KW; Li PK
    J Steroid Biochem Mol Biol; 1999 Jan; 68(1-2):31-40. PubMed ID: 10215035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo activity of 4-methylcoumarin-7-O-sulfamate, a nonsteroidal, nonestrogenic steroid sulfatase inhibitor.
    Purohit A; Woo LW; Singh A; Winterborn CJ; Potter BV; Reed MJ
    Cancer Res; 1996 Nov; 56(21):4950-5. PubMed ID: 8895749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of fluorinated N-benzoyl and N-phenylacetoyl derivatives of 3-(4-aminophenyl)-coumarin-7-O-sulfamate as steroid sulfatase inhibitors.
    Daśko M; Przybyłowska M; Rachon J; Masłyk M; Kubiński K; Misiak M; Składanowski A; Demkowicz S
    Eur J Med Chem; 2017 Mar; 128():79-87. PubMed ID: 28152429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrophobicity, a physicochemical factor in the inhibition of the enzyme estrone sulfatase (ES).
    Ahmed S; James K; Owen CP; Patel CK; Patel M
    Bioorg Med Chem Lett; 2001 Sep; 11(18):2525-8. PubMed ID: 11549461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of estrone sulfatase and proliferation of human breast cancer cells by nonsteroidal (p-O-sulfamoyl)-N-alkanoyl tyramines.
    Selcer KW; Hegde PV; Li PK
    Cancer Res; 1997 Feb; 57(4):702-7. PubMed ID: 9044848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen O-sulfamates and their analogues: Clinical steroid sulfatase inhibitors with broad potential.
    Thomas MP; Potter BV
    J Steroid Biochem Mol Biol; 2015 Sep; 153():160-9. PubMed ID: 25843211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo inhibition of estrone sulfatase activity and growth of nitrosomethylurea-induced mammary tumors by 667 COUMATE.
    Purohit A; Woo LW; Potter BV; Reed MJ
    Cancer Res; 2000 Jul; 60(13):3394-6. PubMed ID: 10910045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and Biological Evaluation of Fluorinated 3-Phenylcoumarin-7-O-Sulfamate Derivatives as Steroid Sulfatase Inhibitors.
    Demkowicz S; Daśko M; Kozak W; Krawczyk K; Witt D; Masłyk M; Kubiński K; Rachon J
    Chem Biol Drug Des; 2016 Feb; 87(2):233-8. PubMed ID: 26280898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scavestrogen sulfamates: correlation between estrone sulfatase inhibiting and antioxidant effects.
    Römer W; Oettel M; Schwarz S
    Can J Physiol Pharmacol; 1998 Feb; 76(2):99-109. PubMed ID: 9635147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of estrone sulfatase by aromatase inhibitor-based estrogen 3-sulfamates.
    Numazawa M; Tominaga T; Watari Y; Tada Y
    Steroids; 2006 May; 71(5):371-9. PubMed ID: 16476457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel inhibitors of the enzyme estrone sulfatase (ES).
    Ahmed S; James K; Owen CP; Patel CK; Patel M
    Bioorg Med Chem Lett; 2001 Mar; 11(6):841-4. PubMed ID: 11277533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-steroidal and steroidal sulfamates: new drugs for cancer therapy.
    Purohit A; Woo LW; Barrow D; Hejaz HA; Nicholson RI; Potter BV; Reed MJ
    Mol Cell Endocrinol; 2001 Jan; 171(1-2):129-35. PubMed ID: 11165021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of placental estrone sulfatase activity and MCF-7 breast cancer cell proliferation by estrone-3-amino derivatives.
    Selcer KW; Jagannathan S; Rhodes ME; Li PK
    J Steroid Biochem Mol Biol; 1996 Sep; 59(1):83-91. PubMed ID: 9009241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of steroid sulfatase by an active site-directed inhibitor, estrone-3-O-sulfamate.
    Purohit A; Williams GJ; Howarth NM; Potter BV; Reed MJ
    Biochemistry; 1995 Sep; 34(36):11508-14. PubMed ID: 7547880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.